These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 13642542)

  • 1. [Studies on the properties of new hemostatic preparations from neutralized oxycellulose; experimental studies].
    UDALOV SK
    Khirurgiia (Mosk); 1959 Feb; 35(2):115-7. PubMed ID: 13642542
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies of intraperitoneal absorption during the use of hemostatic sponge preparations].
    NOLD B; STEGMANN H
    Gynaecologia; 1958 Mar; 145(3):180-9. PubMed ID: 13538351
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies on the absorption & local compatibility of implanted hemostatic foam preparations].
    ZBINDEN G; STUDER A
    Schweiz Z Pathol Bakteriol; 1957; 20(4):469-87. PubMed ID: 13495394
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental and clinical studies on hesna (hemostatic agent) in urological field].
    SAMESHIMA H
    Hinyokika Kiyo; 1962 Sep; 8():559-64. PubMed ID: 13991307
    [No Abstract]   [Full Text] [Related]  

  • 5. The hemostatic, laxative and toxic effects of alginic acid preparations.
    THIENES CH; SKILLEN RG; MEREDITH OM; FAIRCHILD MD; McCANDLESS RS; THIENES RP
    Arch Int Pharmacodyn Ther; 1957 Jul; 111(2):167-81. PubMed ID: 13459502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative evaluation of hemostatic absorbable preparations].
    KUKEL' AS; SAZONOVA GZ
    Probl Gematol Pereliv Krovi; 1959 Apr; 4(4):53-6. PubMed ID: 13658095
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxide hemostatic activity.
    Ostomel TA; Shi Q; Stucky GD
    J Am Chem Soc; 2006 Jul; 128(26):8384-5. PubMed ID: 16802788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine.
    Kheirabadi BS; Edens JW; Terrazas IB; Estep JS; Klemcke HG; Dubick MA; Holcomb JB
    J Trauma; 2009 Feb; 66(2):316-26; discussion 327-8. PubMed ID: 19204503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application hemostatic drug in capillary-parenchymatous bleeding].
    Belozerskaia GG; Makarov VA; Aboiants RK; Istranov LP; Malykhina LS; Zhidkov EA
    Khirurgiia (Mosk); 2004; (9):55-9. PubMed ID: 15477816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative purity of thrombin-based hemostatic agents used in surgery.
    Schoenecker JG; Johnson RK; Fields RC; Lesher AP; Domzalski T; Baig K; Lawson JH; Parker W
    J Am Coll Surg; 2003 Oct; 197(4):580-90. PubMed ID: 14522327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observations on the use in otorhinolaryngology of a new hemostatic: the sulfone ester of adrenochrome semicarbazone].
    DE MITRI T
    Minerva Med; 1963 Feb; 54():536-8. PubMed ID: 14025954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of a new synthetic hemostatic, cyclonamine (Dicynone) used prophylactically in operative ophthalmology].
    STUCCHI CA; NOURI A
    Ther Umsch; 1962 Nov; 19():481-3. PubMed ID: 13993252
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-adhesion properties of a thrombin-based hemostatic gelatin in a canine laminectomy model: a biomechanical, biochemical, and histologic study.
    Miyamoto K; Masuda K; Inoue N; Okuma M; Muehleman C; An HS
    Spine (Phila Pa 1976); 2006 Feb; 31(4):E91-7. PubMed ID: 16481942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
    Mathiasen RA; Cruz RM
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction.
    Patatanian E; Fugate SE
    Ann Pharmacother; 2006 Dec; 40(12):2205-10. PubMed ID: 17090725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of structural and hemostatic properties of the poly-N-acetyl glucosamine Syvek Patch with products containing chitosan.
    Fischer TH; Connolly R; Thatte HS; Schwaitzberg SS
    Microsc Res Tech; 2004 Feb; 63(3):168-74. PubMed ID: 14755604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a new fibrin sealant with standard topical hemostatic agents.
    Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
    Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial.
    Huri E; Akgül T; Ayyildiz A; Ustün H; Germiyanoğlu C
    J Urol; 2009 May; 181(5):2349-54. PubMed ID: 19303089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of hemostatic agents on peripheral nerve function: an experimental study.
    Alkan A; Inal S; Yildirim M; Baş B; Ağar E
    J Oral Maxillofac Surg; 2007 Apr; 65(4):630-4. PubMed ID: 17368355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage.
    Ward KR; Tiba MH; Holbert WH; Blocher CR; Draucker GT; Proffitt EK; Bowlin GL; Ivatury RR; Diegelmann RF
    J Trauma; 2007 Aug; 63(2):276-83; discussion 283-4. PubMed ID: 17693824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.